Role of laboratory investigations to assess maternal and perinatal outcome in hypertensive mothers

D. S. Preethi, Lavanya Rai, M. Jayaraman Nambiar, Pratap Kumar, Muralidhar V. Pai, Sapna V. Amin

Research output: Contribution to journalArticle

Abstract

Introduction: The aim of this study was to evaluate the relevance of routinely done laboratory parameters in women with hypertensive disorders in pregnancy. Materials and methods: Hypertensive pregnant women were divided into two groups based on perinatal outcome as those with and without poor perinatal outcome. They were analyzed with various laboratory tests done at the time of diagnosis: Hematological parameters, such as hemoglobin, hematocrit, platelet count, total leukocyte count, and differential count; renal parameters, such as serum urea, creatinine, and uric acid; liver function tests; and serum lactate dehydrogenase (LDH). Coagulation parameters, such as prothrombin time, activated partial thromboplastin time, and international normalized ratio were compared between the two groups. Data were presented as mean ± standard deviation; α level of p < 0.05 was set as statistically significant. Results: Among the various hematological parameters, platelet count showed statistically significant differences between hypertensives with and without perinatal mortality or morbidity (p = 0.029, p = 0.029 respectively). All renal parameters showed statistically significant differences (p ≤ 0.005). Serum aspartate aminotransferase (p = 0.034) among the liver parameters and serum LDH (p = 0.024) showed statistically significant differences between the two groups. Coagulation parameters were abnormal among patients with thrombocytopenia. Conclusion: Blood pressure alone is not sufficient in monitoring women with hypertensive disorders in pregnancy. Laboratory parameters that are cost-effective and routinely done in most laboratories are significant in assessing the severity of maternal disease and the perinatal outcome. It can hence, be used to monitor hypertensive women in pregnancy.

Original languageEnglish
Pages (from-to)18-23
Number of pages6
JournalInternational Journal of Infertility and Fetal Medicine
Volume8
Issue number1
DOIs
Publication statusPublished - 01-01-2017

Fingerprint

Mothers
Serum
Platelet Count
L-Lactate Dehydrogenase
Pregnancy
Kidney
International Normalized Ratio
Partial Thromboplastin Time
Perinatal Mortality
Liver Function Tests
Prothrombin Time
Aspartate Aminotransferases
Uric Acid
Leukocyte Count
Hematocrit
Thrombocytopenia
Urea
Pregnant Women
Creatinine
Hemoglobins

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine

Cite this

@article{55f9026f757f40f78c8f691bbf7b12a4,
title = "Role of laboratory investigations to assess maternal and perinatal outcome in hypertensive mothers",
abstract = "Introduction: The aim of this study was to evaluate the relevance of routinely done laboratory parameters in women with hypertensive disorders in pregnancy. Materials and methods: Hypertensive pregnant women were divided into two groups based on perinatal outcome as those with and without poor perinatal outcome. They were analyzed with various laboratory tests done at the time of diagnosis: Hematological parameters, such as hemoglobin, hematocrit, platelet count, total leukocyte count, and differential count; renal parameters, such as serum urea, creatinine, and uric acid; liver function tests; and serum lactate dehydrogenase (LDH). Coagulation parameters, such as prothrombin time, activated partial thromboplastin time, and international normalized ratio were compared between the two groups. Data were presented as mean ± standard deviation; α level of p < 0.05 was set as statistically significant. Results: Among the various hematological parameters, platelet count showed statistically significant differences between hypertensives with and without perinatal mortality or morbidity (p = 0.029, p = 0.029 respectively). All renal parameters showed statistically significant differences (p ≤ 0.005). Serum aspartate aminotransferase (p = 0.034) among the liver parameters and serum LDH (p = 0.024) showed statistically significant differences between the two groups. Coagulation parameters were abnormal among patients with thrombocytopenia. Conclusion: Blood pressure alone is not sufficient in monitoring women with hypertensive disorders in pregnancy. Laboratory parameters that are cost-effective and routinely done in most laboratories are significant in assessing the severity of maternal disease and the perinatal outcome. It can hence, be used to monitor hypertensive women in pregnancy.",
author = "Preethi, {D. S.} and Lavanya Rai and Nambiar, {M. Jayaraman} and Pratap Kumar and Pai, {Muralidhar V.} and Amin, {Sapna V.}",
year = "2017",
month = "1",
day = "1",
doi = "10.5005/jp-journals-10016-1142",
language = "English",
volume = "8",
pages = "18--23",
journal = "International Journal of Infertility and Fetal Medicine",
issn = "2229-3817",
publisher = "Jaypee Brothers Medical Publishers (P) Ltd",
number = "1",

}

Role of laboratory investigations to assess maternal and perinatal outcome in hypertensive mothers. / Preethi, D. S.; Rai, Lavanya; Nambiar, M. Jayaraman; Kumar, Pratap; Pai, Muralidhar V.; Amin, Sapna V.

In: International Journal of Infertility and Fetal Medicine, Vol. 8, No. 1, 01.01.2017, p. 18-23.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of laboratory investigations to assess maternal and perinatal outcome in hypertensive mothers

AU - Preethi, D. S.

AU - Rai, Lavanya

AU - Nambiar, M. Jayaraman

AU - Kumar, Pratap

AU - Pai, Muralidhar V.

AU - Amin, Sapna V.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Introduction: The aim of this study was to evaluate the relevance of routinely done laboratory parameters in women with hypertensive disorders in pregnancy. Materials and methods: Hypertensive pregnant women were divided into two groups based on perinatal outcome as those with and without poor perinatal outcome. They were analyzed with various laboratory tests done at the time of diagnosis: Hematological parameters, such as hemoglobin, hematocrit, platelet count, total leukocyte count, and differential count; renal parameters, such as serum urea, creatinine, and uric acid; liver function tests; and serum lactate dehydrogenase (LDH). Coagulation parameters, such as prothrombin time, activated partial thromboplastin time, and international normalized ratio were compared between the two groups. Data were presented as mean ± standard deviation; α level of p < 0.05 was set as statistically significant. Results: Among the various hematological parameters, platelet count showed statistically significant differences between hypertensives with and without perinatal mortality or morbidity (p = 0.029, p = 0.029 respectively). All renal parameters showed statistically significant differences (p ≤ 0.005). Serum aspartate aminotransferase (p = 0.034) among the liver parameters and serum LDH (p = 0.024) showed statistically significant differences between the two groups. Coagulation parameters were abnormal among patients with thrombocytopenia. Conclusion: Blood pressure alone is not sufficient in monitoring women with hypertensive disorders in pregnancy. Laboratory parameters that are cost-effective and routinely done in most laboratories are significant in assessing the severity of maternal disease and the perinatal outcome. It can hence, be used to monitor hypertensive women in pregnancy.

AB - Introduction: The aim of this study was to evaluate the relevance of routinely done laboratory parameters in women with hypertensive disorders in pregnancy. Materials and methods: Hypertensive pregnant women were divided into two groups based on perinatal outcome as those with and without poor perinatal outcome. They were analyzed with various laboratory tests done at the time of diagnosis: Hematological parameters, such as hemoglobin, hematocrit, platelet count, total leukocyte count, and differential count; renal parameters, such as serum urea, creatinine, and uric acid; liver function tests; and serum lactate dehydrogenase (LDH). Coagulation parameters, such as prothrombin time, activated partial thromboplastin time, and international normalized ratio were compared between the two groups. Data were presented as mean ± standard deviation; α level of p < 0.05 was set as statistically significant. Results: Among the various hematological parameters, platelet count showed statistically significant differences between hypertensives with and without perinatal mortality or morbidity (p = 0.029, p = 0.029 respectively). All renal parameters showed statistically significant differences (p ≤ 0.005). Serum aspartate aminotransferase (p = 0.034) among the liver parameters and serum LDH (p = 0.024) showed statistically significant differences between the two groups. Coagulation parameters were abnormal among patients with thrombocytopenia. Conclusion: Blood pressure alone is not sufficient in monitoring women with hypertensive disorders in pregnancy. Laboratory parameters that are cost-effective and routinely done in most laboratories are significant in assessing the severity of maternal disease and the perinatal outcome. It can hence, be used to monitor hypertensive women in pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=85026254396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026254396&partnerID=8YFLogxK

U2 - 10.5005/jp-journals-10016-1142

DO - 10.5005/jp-journals-10016-1142

M3 - Article

VL - 8

SP - 18

EP - 23

JO - International Journal of Infertility and Fetal Medicine

JF - International Journal of Infertility and Fetal Medicine

SN - 2229-3817

IS - 1

ER -